Inhibition of morphine antinociception by centrally administered histamine H2 receptor antagonists.

[1]  L. Hough,et al.  Modulation of morphine antinociception by antagonism of H2 receptors in the periaqueductal gray , 1992, Brain Research.

[2]  J. Nalwalk,et al.  Differential effects of morphine on histamine metabolism in brain and spinal cord of mice , 1990, Brain Research.

[3]  J. Nalwalk,et al.  Actions of morphine on histamine dynamics in the mouse brain: a strain comparison. , 1990, Biochemical pharmacology.

[4]  U. Pirvola,et al.  Histamine-immunoreactive nerve fibers in the rat brain , 1989, Neuroscience.

[5]  R. C. Young,et al.  A role for histamine and H2-receptors in opioid antinociception. , 1989, The Journal of pharmacology and experimental therapeutics.

[6]  E. Fuchs,et al.  Histamine-immunoreactive nerve fibers in the mammalian spinal cord , 1989, Brain Research.

[7]  K. Hole,et al.  An improved method for tail-flick testing with adjustment for tail-skin temperature , 1989, Journal of Neuroscience Methods.

[8]  L. Hough Cellular localization and possible functions for brain histamine: Recent progress , 1988, Progress in Neurobiology.

[9]  D. Cue,et al.  Actions of the brain-penetrating H2-antagonist zolantidine on histamine dynamics and metabolism in rat brain. , 1988, Biochemical pharmacology.

[10]  P. Panula,et al.  The histaminergic system in the guinea pig central nervous system: An immunocytochemical mapping study using an antiserum against histamine , 1988, The Journal of comparative neurology.

[11]  R. C. Young,et al.  Zolantidine (SK&F 95282) is a potent selective brain‐penetrating histamine H2‐receptor antagonist , 1988, British journal of pharmacology.

[12]  J. Liebeskind,et al.  Differential effects of scopolamine on 3 forms of stress analgesia , 1985, Brain Research.

[13]  M. Nishibori,et al.  Morphine‐Induced Changes in Histamine Dynamics in Mouse Brain , 1985, Journal of neurochemistry.

[14]  S. D. Glick,et al.  Simple cannula for repeated intracerebral drug administration in rats , 1979, Pharmacology Biochemistry and Behavior.

[15]  S. D. Glick,et al.  Opiate-like and abstinence-like effects of intracerebral histamine administration in rats , 1978, Nature.

[16]  Tony L. Yaksh,et al.  Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques , 1977, Pain.

[17]  T. Yaksh,et al.  Systematic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effects within the periaqueductal gray , 1976, Brain Research.

[18]  A. Lajtha,et al.  The periaqueductal gray: Site of morphine analgesia and tolerance as shown by 2-way cross tolerance between systemic and intracerebral injections , 1976, Brain Research.

[19]  N. B. Eddy,et al.  Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. , 1953, The Journal of pharmacology and experimental therapeutics.

[20]  Fred E. D'Amour,et al.  A METHOD FOR DETERMINING LOSS OF PAIN SENSATION , 1941 .

[21]  L. Hough,et al.  Inhibition of naloxone-resistant antinociception by centrally administered H2-antagonists. , 1989, The Journal of pharmacology and experimental therapeutics.

[22]  A I Basbaum,et al.  Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. , 1984, Annual review of neuroscience.

[23]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[24]  C. Ganellin,et al.  Chapter Two – Chemistry and Structure—Activity Relationships of Drugs Acting at Histamine Receptors , 1982 .